FDA Approves Juluca (dolutegravir and rilpivirine) for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection

November 21, 2017 — The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs…

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us